![All lanes : Anti-HRASLS3 antibody [1A5] (ab180392) at 1/4000 dilutionLane 1 : HEK293T cells transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cells transfected with pCMV6-ENTRY HRASLS3 cDNALysates/proteins at 5 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_3/4195_ab180392-209105-ab180392wb1.jpg)
All lanes : Anti-HRASLS3 antibody [1A5] (ab180392) at 1/4000 dilutionLane 1 : HEK293T cells transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cells transfected with pCMV6-ENTRY HRASLS3 cDNALysates/proteins at 5 µg per lane.

Immunohistochemical analysis of paraffin embedded Human liver tissue labeling HRASLS3 with ab180392 at a 1/150 dilution.

Immunohistochemical analysis of paraffin embedded Human liver carcinoma tissue labeling HRASLS3 with ab180392 at a 1/150 dilution.

Immunohistochemical analysis of paraffin embedded Human pancreas tissue labeling HRASLS3 with ab180392 at a 1/150 dilution.

Immunohistochemical analysis of paraffin embedded Human pancreas carcinoma tissue labeling HRASLS3 with ab180392 at a 1/150 dilution.

Immunohistochemical analysis of paraffin embedded Human prostate tissue labeling HRASLS3 with ab180392 at a 1/150 dilution.

Immunohistochemical analysis of paraffin embedded Human prostate carcinoma tissue labeling HRASLS3 with ab180392 at a 1/150 dilution.

Immunofluorescence analysis of COS7 cells transiently transfected by pCMV6-ENTRY HRASLS3 using ab180392 at a 1/100 dilution.